Publication Name	World Journal of Hepatology
Manuscript ID	26018
Country	France

Received	2016-03-28 10:38
Peer-Review Started	2016-03-28 10:55
To Make the First Decision	2016-05-17 12:19
Return for Revision	2016-05-18 11:35
Revised	2016-05-30 17:39
Second Decision	2016-06-13 16:59
Accepted by Journal Editor-in-Chief	2016-06-13 17:49
Accepted by Company Editor-in-Chief	2016-06-29 10:00
Articles in Press	2016-06-29 10:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-07-11 16:03
Publish the Manuscript Online	2016-07-22 10:22

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Bérénice Charrière, Charlotte Maulat, Bertrand Suc and Fabrice Muscari
Funding Agency and Grant Number
Corresponding Author	Fabrice Muscari, Professor, Service de Chirurgie Digestive, CHU Toulouse Rangueil, 1 Avenue du Pr. Jean Poulhès, Cedex 9, 31059 Toulouse, France. muscari.f@chu-toulouse.fr
Key Words	Hepatocellular carcinoma; Downstaging; Alpha-fetoprotein; Liver transplantation; Selection criteria
Core Tip	Alpha-fetoprotein (AFP) is the main biomarker available for the management of hepatocellular carcinoma (HCC). Yet, its contribution in liver transplantation for HCC has not been fully determined. We discuss the interest of AFP as a prognostic factor to predict tumor recurrence after liver transplantation, and as a selection tool to assess the best candidates to receive a graft. We also provide an overview of the different ways that AFP could be included in decisional algorithms before liver transplantation, through its static and dynamic values.
Publish Date	2016-07-22 10:22
Citation	Charrière B, Maulat C, Suc B, Muscari F. Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World J Hepatol 2016; 8(21): 881-890
URL	http://www.wjgnet.com/1948-5182/full/v8/i21/881.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i21.881

Full Article (PDF)	WJH-8-881.pdf
Full Article (Word)	WJH-8-881.doc
Manuscript File	26018-Review.doc
Answering Reviewers	26018-Answering reviewers.pdf
Audio Core Tip	26018-Audio Core tip.mp3
Conflict-of-Interest Disclosure Form	26018-Conflict-of-interest statement.pdf
Copyright License Agreement	26018-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	26018-Language certificate.pdf
Peer-review Report	26018-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	26018-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	26018-Scientific misconduct check.pdf
Scientific Editor Work List	26018-Scientific editor work list.pdf